In NF1, CFTR, PER3, CARS and SYT7 , alternatively included exons show higher conservation of surrounding intron sequences than constitutive exons

European Journal of Human Genetics

Volumn 12, Issue 2, 2004, Pages 139-149

  Kaufmann, Dieter ^a   Kenner, Oliver ^a   Nurnberg, Peter ^b   Vogel, Walther ^a   Bartelt, Britta ^a  

^a UNIVERSITY OF ULM   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Alternative splicing; Alternatively included; Intron conservation

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; CYSTEINE TRANSFER RNA; NEUROFIBROMIN; SYNAPTOTAGMIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWNSTREAM PROCESSING; EXON; GENE CASSETTE; GENE SEQUENCE; GENETIC CONSERVATION; GENETIC REGULATION; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

ALTERNATIVE SPLICING; AMINO ACYL-TRNA SYNTHETASES; ANIMALS; BASE SEQUENCE; CALCIUM-BINDING PROTEINS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA PRIMERS; EXONS; GENES, NEUROFIBROMATOSIS 1; HUMANS; INTRONS; MEMBRANE GLYCOPROTEINS; MICE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; SEQUENCE HOMOLOGY, NUCLEIC ACID; SYNAPTOTAGMINS; TRANSCRIPTION FACTORS;

EID: 1342346035     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201098     Document Type: Article

References (49)

1. Zhang MQ: Computational prediction of eukaryotic protein-coding genes. Nat Rev Genet 2002; 3: 698-709.
2. Cartegni L, Chew SL, Krainer AR: Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 2002; 3: 285-298.
3. Ladd AN, Cooper TA: Finding signals that regulates alternative splicing in the postgenomic era. Genome Biol 2002; 3: (reviews0008.1-0008.16.).
4. Nogués G, Kadener S, Cramer P, Bentley D, Kornblihtt AR: Transcriptional activators differ in their abilities to control alternative splicing. J Biol Chem 2002; 277: 43110 43114.
5. Clark F, Thanaraj TA: Categorization and characterization of transcript-confirmed constitutively and alternatively spliced introns and exons from human. Hum Mol Genet 2002; 11: 451 464.
6. Loots GG, Locksley RM, Blankespoor CM et al: Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science 2000; 288: 136 140.
7. Mouse Genome Sequencing Consortium: Initial sequencing and comparative analysis of the mouse genome. Nature 2002; 420: 520 562.
8. Shen MH, Harper PS, Upadhyaya M: Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet 1996; 33: 2 17.
9. Cichowski K, Jacks T: NF1 tumor suppressor gene function: narrowing the GAP. Cell 2001; 104: 593 604.
10. Kaufmann D, Muller R, Kenner O et al: The N-terminal splice product NF1-10a-2 of the NF1 gene codes for a transmembrane segment. Biochem Biophys Res Commun 2002; 294: 496 503.
11. Mantani A, Wakasugi S, Yokota Y, Abe K, Ushio Y, Yamamura K: A novel isoform of the neurofibromatosis type-1 mRNA and a switch of isoforms during murine cell differentiation and proliferation. Gene 1994; 148: 245 251.
12. Vandenbroucke I, Vandesompele J, De Paepe A, Messiaen L: Quantification of NF1 transcripts reveals novel highly expressed splice variants. FEBS Lett 2002; 522: 71 76.
13. Wimmer K, Eckart M, Rehder H, Fonatsch C: Illegitimate splicing of the NF1 gene in healthy individuals mimics mutation-induced splicing alterations in NF1 patients. Hum Genet 2000; 106: 311 313.
14. Kaufmann D, Leistner W, Kruse P et al: Aberrant splicing in several human tumors in the tumor suppressor genes neurofibromatosis type 1, neurofibromatosis type 2, and tuberous sclerosis 2. Cancer Res 2002; 62: 1503 1509.
15. Thomson SA, Wallace MR: 2002) RT-PCR splicing analysis of the NF1 open reading frame. Hum Genet 2002; 110: 495 502.
16. Jensen KB, Dredge BK, Stefani G et al: Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability. Neuron 2000; 25: 359 371.
17. Sirand-Pugnet F, Durosay P, Brody E, Marie J: An intronic (A/U)GGG repeat enhances the splicing of an alternative intron of the chicken beta-tropomyosin pre-mRNA. Nucleic Acids Res 1995; 23: 3501 3507.
18. Chou MY, Underwood JG, Nikolic J, Luu MH, Black DL: Multisite RNA binding and release of polypyrimidine tract binding protein during the regulation of c-src neural-specific splicing. Mol Cell 2000; 5: 949 957.
19. Carlo T, Sierra R, Berget SM: A 5′ splice site-proximal enhancer binds SF1 and activates exon bridging of a microexon. Mol Cell Biol 2000; 20: 3988 3995.
20. Modafferi EF, Black DL: A complex intronic splicing enhancer from the c-src pre-mRNA activates inclusion of a heterologous exon. Mol Cell Biol 1997; 17: 6537 6545.
21. Chabot B, Blanchette M, Lapierre I, La Branche H: An intron element modulating 5′ splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1. Mol Cell Biol 1997; 17: 1776 1786.
22. Jin W, Bi W, Huang ESC, Cote GJ: Glioblastoma cell-specific expression of fibroblast growth factor receptor-1β requires an intronic repressor of RNA splicing. Cancer Res 1999; 59: 316 319.
23. Pret AM, Balvay L, Fiszman MY: Regulated splicing of an alternative exon of beta-tropomyosin pre-mRNAs in myogenic cells depends on the strength of pyrimidine-rich intronic enhancer elements. DNA Cell Biol 1999; 18: 671 683.
24. Blanchette M, Chabot B: Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization. EMBO J 1999; 18: 1939 1952.
25. del Gatto F, Plet A, Gesnel MC, Fort C, Breathnach R: Multiple interdependent sequence elements control splicing of a fibroblast growth factor receptor 2 alternative exon. Mol Cell Biol 1997; 17: 5106 5116.
26. Lou H, Yang Y, Cote GJ, Berget SM, Gagel RF: An intron enhancer containing a 5′ splice site sequence in the human calcitonin/calcitonin gene-related paptide gene. Mol Cell Biol 1995; 15: 7135 7142.
27. Markovtsov V, Nikolic JM, Goldman JA, Turck CW, Chou MY, Black DL: Cooperative assembly of an hnRNP complex induced by a tissue-specific homolog of polypyrimidine tract binding protein. Mol Cell Biol 2000; 20: 7463 7479.
28. Standiford DM, Sun WT, Davis MB, Emerson Jr CP: Positive and negative intronic regulatory elements control muscle-specific alternative exon splicing of drosophila myosin heavy chain transcripts. Genetics 2001; 157: 259 271.
29. Cooper TA: Muscle-specific splicing of a heterologous exon mediated by a single muscle-specific splicing enhancer from the cardiac troponin T gene. Mol Cell Biol 1998; 18: 4519 4525.
30. Zhang MQ: Identification of human gene core promoters in silico. Genome Res 1998; 8: 319 326.
31. Knudsen S: Promoter2.0: for the recognition of Pol II promoter sequences. Bioinformatics 1999; 15: 356 361.
32. Boyd DC, Turner PC, Watkins NJ, Gerster T, Murphy S: Functional redundancy of promoter elements ensures efficient transcription of the human 7SK gene in vivo. J Mol Biol 1995; 253: 677 690.
33. Weinstein LB, Steitz JA: Guided tours: from precursor snoRNA to functional snoRNA. Curr Opin Cell Biol 1999; 11: 378 384.
34. Hedges SB, Kumar S: Vertebrate genomes compared. Science 2002; 297: 1283 1285.
35. Melo CA, Serra C, Stoyanova V et al: Alternative splicing of a previously unidentified CFTR exon induces an in-frame stop codon 5′ of the R region. FEBS Lett 1993; 329: 159 162.
36. Zylka MJ, Shearman LP, Weaver DR, Reppert SM: Three period homologs in mammals: differential light responses in the suprachiasmatic circadian clock and oscillating transcripts outside of brain. Neuron 1998; 20: 1103 1110.
37. Kim JE, Kim KH, Lee SW, Seol W, Shiba K, Kim S: An elongation factor-associating domain is inserted into human cysteinyl-tRNA synthetase by alternative splicing. Nucleic Acids Res 2000; 28: 2866 2872.
38. Fukuda M, Ogata Y, Saegusa C, Kanno E, Mikoshiba K: Alternative splicing isoforms of synaptotagmin VII in the mouse, rat and human. Biochem J 2002; 365: 173 180.
39. Hull J, Shackleton S, Harris A: Analysis of mutations and alternative splicing patterns in the CFTR gene using mRNA derived from nasal epithelial cells. Hum Mol Genet 1994; 3: 1141 1146.
40. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call MK, Housman DE: Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci USA 1991; 88: 9618 9622.
41. Ellenrieder C, Bartosch B, Lee GY et al: The long form of CDK2 arises via alternative splicing and forms an active protein kinase with cyclins A and E. DNA and Cell Biol 2001; 20: 413 423.
42. Jaworski C, Sperbeck S, Graham C, Wistow G: Alternative splicing of Pax6 in bovine eye and evolutionary conservation of intron sequences. Biochem Biophys Res Commun 1997; 240: 196 202.
43. Modrek B, Resch A, Grasso C, Lee C: Genome-wide detection of alternative splicing in expressed sequences of human genes. Nucleic Acids Res 2001; 29: 2850 2859.
44. Zavolan M, Van Nimwegen E, Gaasterland T: Splice variation in mouse full-length cDNAs identified by mapping to the mouse genome. Genome Res 2002; 12: 1377 1385.
45. Xuan Z, Wang J, Zhang MQ: Computational comparison of two mouse draft genomes and the human golden path. Genome Biol 2002; 4: R1.
46. Coleman TP, Roesser JR: RNA secondary structure: an important cis-element in rat calcitonin/CGRP pre-messenger RNA splicing. Biochemistty 1998; 37: 15941-15950.
47. Li AW, Murphy PR: Expression of alternatively spliced FGF-2 antisense RNA transcripts in the central nervous system: regulation of FGF-2 mRNA translation. Mol Cell Endocrinol 2000; 170: 233-242.
48. Thenie AC, Gicquel IM, Hardy S et al: Identification of an endogenous RNA transcribed from the antisense strand of the HFE gene. Hum Mol Gen 2001; 10: 1859-1866.
49. Rettenberger G, Klett C, Zechner U et al: ZOO-FISH analysis: cat and human karyotypes closely resemble the putative ancestral mammalian karyotype. Chromosome Res 1995; 13: 479-486.